463 related articles for article (PubMed ID: 22080874)
1. Can noninvasive evaluation of benign prostatic obstruction be optimized?
Løvvik A; Yaqub S; Oustad H; Sand TE; Nitti VW
Curr Opin Urol; 2012 Jan; 22(1):1-6. PubMed ID: 22080874
[TBL] [Abstract][Full Text] [Related]
2. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Suzuki T; Otsuka A; Ozono S
Int J Urol; 2016 Nov; 23(11):929-933. PubMed ID: 27545297
[TBL] [Abstract][Full Text] [Related]
3. Imaging in benign prostatic hyperplasia: what is new?
Abdi H; Kazzazi A; Bazargani ST; Djavan B; Telegrafi S
Curr Opin Urol; 2013 Jan; 23(1):11-6. PubMed ID: 23138467
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
5. Benign prostatic hyperplasia: clinical manifestations and evaluation.
Santos Dias J
Tech Vasc Interv Radiol; 2012 Dec; 15(4):265-9. PubMed ID: 23244722
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound assessment of intravesical prostatic protrusion and detrusor wall thickness--new standards for noninvasive bladder outlet obstruction diagnosis?
Franco G; De Nunzio C; Leonardo C; Tubaro A; Ciccariello M; De Dominicis C; Miano L; Laurenti C
J Urol; 2010 Jun; 183(6):2270-4. PubMed ID: 20400138
[TBL] [Abstract][Full Text] [Related]
7. Association of high bladder neck elevation with urodynamic bladder outlet obstruction in patients with lower urinary tract symptoms and benign prostatic hyperplasia.
Kang M; Kim M; Choo MS; Bae J; Ku JH; Yoo C; Oh SJ
Urology; 2014 Dec; 84(6):1461-6. PubMed ID: 25432841
[TBL] [Abstract][Full Text] [Related]
8. Resistive index of prostate capsular arteries: a newly identified parameter to diagnose and assess bladder outlet obstruction in patients with benign prostatic hyperplasia.
Zhang X; Li G; Wei X; Mo X; Hu L; Zha Y; Hou J
J Urol; 2012 Sep; 188(3):881-7. PubMed ID: 22819411
[TBL] [Abstract][Full Text] [Related]
9. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
van Venrooij GE; Eckhardt MD; Boon TA
Urology; 2004 Mar; 63(3):476-80. PubMed ID: 15028441
[TBL] [Abstract][Full Text] [Related]
10. Intravesical prostatic protrusion can predict therapeutic response to silodosin in male patients with lower urinary tract symptoms.
Matsukawa Y; Ishida S; Majima T; Funahashi Y; Sassa N; Kato M; Yoshino Y; Gotoh M
Int J Urol; 2017 Jun; 24(6):454-459. PubMed ID: 28370376
[TBL] [Abstract][Full Text] [Related]
11. Detrusor underactivity in men with lower urinary tract symptoms/benign prostatic obstruction: characterization and potential impact on indications for surgical treatment of the prostate.
Rademakers KL; van Koeveringe GA; Oelke M
Curr Opin Urol; 2016 Jan; 26(1):3-10. PubMed ID: 26574876
[TBL] [Abstract][Full Text] [Related]
12. Modern evaluation of lower urinary tract symptoms in 2014.
Mangera A; Chapple C
Curr Opin Urol; 2014 Jan; 24(1):15-20. PubMed ID: 24253800
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive methods to evaluate bladder obstruction in men.
Elterman DS; Chughtai B; Lee R; Te AE; Kaplan SA
Int Braz J Urol; 2013; 39(1):4-9. PubMed ID: 23489514
[TBL] [Abstract][Full Text] [Related]
14. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
[TBL] [Abstract][Full Text] [Related]
15. Multichannel urodynamic studies in men with benign prostatic hyperplasia. Indications and interpretation.
Blaivas JG
Urol Clin North Am; 1990 Aug; 17(3):543-52. PubMed ID: 1695781
[TBL] [Abstract][Full Text] [Related]
16. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
[TBL] [Abstract][Full Text] [Related]
17. The Diagnosis of Benign Prostatic Obstruction: Validation of the Young Academic Urologist Clinical Nomogram.
De Nunzio C; Lombardo R; Gacci M; Milanesi M; Cancrini F; Tema G; Cocci A; Giordano G; Leonardo C; Carini M; Tubaro A
Urology; 2015 Nov; 86(5):1032-6. PubMed ID: 26284594
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and differential diagnosis of benign prostatic hypertrophy.
Blaivas JG
Urology; 1988 Dec; 32(6 Suppl):5-11. PubMed ID: 2462303
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of the diagnostic criteria of bladder outlet obstruction in benign prostatic hyperplasia].
Shuang W; Wang D; Zhang X; Liu C; Cao X; Wang J; Gao J; Ren Z; Lü Y
Zhonghua Nan Ke Xue; 2004 Oct; 10(10):743-6. PubMed ID: 15562786
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia].
Bantis A; Zissimopoulos A; Kalaytzis C; Giannakopoulos S; Sountoulides P; Agelonidou E; Voudalikakis C; Touloupidis S
Hell J Nucl Med; 2007; 10(2):138-43. PubMed ID: 17684595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
